Merck researchers need to navigate large data sets, refine hypotheses, and complete repetitive and differentiated analysis tasks more efficiently during drug discovery and development.
Reported impact
Merck says the AI agents help accelerate drug discovery and development work by automating lower-level analysis tasks and increasing researcher speed at scale while keeping scientists in the decision loop.
Merck Research Labs describes using large language model-based AI agents as an internal research assistance layer for drug discovery and development. According to the story, these agents combine LLMs, AI models, and tools so complex scientific work can be broken into manageable subtasks, planned iteratively, and executed across multiple specialized assistants. Merck says the approach helps researchers navigate large data sets, refine hypotheses, and automate repetitive work such as data cleaning and preliminary analysis before results are returned to scientists for higher-level interpretation and decision-making. The article positions the system as an augmentation of human researchers and as an extension of Merck’s existing AI/ML investments. It does not name external vendors, model platforms, storage systems, or serving infrastructure, so the disclosed implementation is limited to an internal agent-based orchestration pattern rather than a detailed architecture stack.
Research data and scientific context are provided to LLM-based AI agents, which decompose drug discovery questions into subtasks, coordinate AI/ML tools for data cleaning and preliminary analysis, and return synthesized outputs to Merck researchers for hypothesis refinement and decision-making. The source does not disclose storage systems or downstream application endpoints.
"AI agents are emerging as a powerful tool for researchers and scientists to aid them in navigating the complexities of large data sets, refining hypotheses and executing both repetitive and differentiated tasks efficiently."
"Agents help capitalize on Merck’s long-standing investments in AI/ML by rapidly accelerating the speed of our human researchers at scale."
"Having a team of high-performing AI assistants that can each play different roles ultimately helps researchers at Merck Research Labs (MRL) focus on critical drug discovery and development."
"Repetitive tasks, such as data cleaning or preliminary analysis, can be handled by AI agents, freeing our scientists to focus on higher level work and strategic decision making."
"These LLM-based multitaskers, often called AI agents, can execute different tasks simultaneously."
Review how this reference was scored and trace each normalized claim back to its documented source.
Scoring methodology
Customer Reference Value measures usefulness as a customer reference. Evidence Confidence measures the quality and traceability of available evidence, not independent verification.
Traceability
Field coverage shows which facts each source supports. Dates are shown only when documented by the source.
Our corporate headquarters is located at: 126 East Lincoln Avenue, P.O. Box 2000, Rahway, NJ 07065 USA.
Related
In-house Sample Jul 28, 2026 Novartis Novartis R&D needs to turn large volumes of scientific, clinical, operational, and real-world data into faster, higher-quality decisions across drug discovery and development, reducing cycle times, surfacing safety… less than 10 percent of drug candidates historically reach the market AI models · AI-enhanced analytics · Generative AI In-house Sample Apr 13, 2026 Elevance Health Elevance Health needed to find fraud, waste, and abuse in very large volumes of claims, payment, contract, and medical-record data so it could detect billing errors, suspicious coding patterns, and improper payments… across an annualized volume of nearly 23,000 reviews In-house Sample Feb 24, 2026 Sanofi Sanofi needed a faster, more objective way to decide which R&D programs to advance, accelerate, or stop while weighing costs, clinical trial enrollment timelines, unmet need, competition, and each program's probability… more than one billion data points across Sanofi Aily Labs · Plai 